BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21669187)

  • 1. The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells.
    Trinks C; Severinsson EA; Holmlund B; Gréen A; Gréen H; Jönsson JI; Hallbeck AL; Walz TM
    Biochem Biophys Res Commun; 2011 Jul; 410(3):422-7. PubMed ID: 21669187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells.
    Trinks C; Djerf EA; Hallbeck AL; Jönsson JI; Walz TM
    Biochem Biophys Res Commun; 2010 Feb; 393(1):6-10. PubMed ID: 20096663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo.
    Djerf Severinsson EA; Trinks C; Gréen H; Abdiu A; Hallbeck AL; Stål O; Walz TM
    Biochem Biophys Res Commun; 2011 Oct; 414(3):563-8. PubMed ID: 21982771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
    Nordigården A; Zetterblad J; Trinks C; Gréen H; Eliasson P; Druid P; Lotfi K; Rönnstrand L; Walz TM; Jönsson JI
    Br J Haematol; 2011 Oct; 155(2):198-208. PubMed ID: 21848891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
    Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
    Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line.
    Lee SH; Park SW; Pyo CW; Yoo NK; Kim J; Choi SY
    Biochimie; 2009 Jan; 91(1):102-8. PubMed ID: 18534198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells.
    Du YW; Liu GC; Wang J; Zhao YP; Li SL; Chen JG; Jiang Q; Cai J; Ma YF
    Ai Zheng; 2009 Feb; 28(2):112-6. PubMed ID: 19550122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits.
    Moos PJ; Fitzpatrick FA
    Cell Growth Differ; 1998 Aug; 9(8):687-97. PubMed ID: 9716185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells.
    Park HS; Jun do Y; Han CR; Woo HJ; Kim YH
    Biochem Pharmacol; 2011 Nov; 82(9):1110-25. PubMed ID: 21819973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways.
    Belka C; Gruber C; Jendrossek V; Wesselborg S; Budach W
    Oncogene; 2003 Jan; 22(2):176-85. PubMed ID: 12527887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells.
    Woo HJ; Jun do Y; Lee JY; Woo MH; Yang CH; Kim YH
    J Ethnopharmacol; 2011 Jun; 135(3):626-35. PubMed ID: 21473903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine kinase p56lck-deficiency confers hypersusceptibility to rho-fluorophenylalanine (pFPhe)-induced apoptosis by augmenting mitochondrial apoptotic pathway in human Jurkat T cells.
    Park HS; Jun DY; Han CR; Kim YH
    Biochem Biophys Res Commun; 2008 Dec; 377(1):280-5. PubMed ID: 18845126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
    Boudreau RT; Conrad DM; Hoskin DW
    Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2'-Nitroflavone induces apoptosis and modulates mitogen-activated protein kinase pathways in human leukaemia cells.
    Cárdenas MG; Blank VC; Marder MN; Roguin LP
    Anticancer Drugs; 2012 Sep; 23(8):815-26. PubMed ID: 22555195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T cell receptor zeta/ZAP-70-dependent and -independent signaling pathways in T cells.
    Deckert M; Ticchioni M; Mari B; Mary D; Bernard A
    Eur J Immunol; 1995 Jul; 25(7):1815-22. PubMed ID: 7542590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of intrinsic and extrinsic pathways in apoptotic signaling during UV-C-induced death of Jurkat cells: the role of caspase inhibition.
    Scoltock AB; Cidlowski JA
    Exp Cell Res; 2004 Jul; 297(1):212-23. PubMed ID: 15194437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells.
    Lang V; Mège D; Semichon M; Gary-Gouy H; Bismuth G
    Eur J Immunol; 1997 Dec; 27(12):3360-7. PubMed ID: 9464824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
    Skov S; Bregenholt S; Claesson MH
    J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells.
    Brünner-Kubath C; Shabbir W; Saferding V; Wagner R; Singer CF; Valent P; Berger W; Marian B; Zielinski CC; Grusch M; Grunt TW
    Breast Cancer Res Treat; 2011 Sep; 129(2):387-400. PubMed ID: 21046231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.